中文版 | English
题名

Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate

作者
通讯作者Li, Zhi-jie; Jiang, Yong; Wang, Ji-gang
发表日期
2023-04-01
DOI
发表期刊
ISSN
1671-4083
EISSN
1745-7254
摘要
Liver, as an immune and detoxification organ, represents an important line of defense against bacteria and infection and a vulnerable organ that is easily injured during sepsis. Artesunate (ART) is an anti-malaria agent, that also exhibits broad pharmacological activities including anti-inflammatory, immune-regulation and liver protection. In this study, we investigated the cellular responses in liver to sepsis infection and ART hepatic-protective mechanisms against sepsis. Cecal ligation and puncture (CLP)-induced sepsis model was established in mice. The mice were administered ART (10 mg/kg, i.p.) at 4 h, and sacrificed at 12 h after the surgery. Liver samples were collected for preparing single-cell RNA transcriptome sequencing (scRNA-seq). The scRNA-seq analysis revealed that sepsis-induced a dramatic reduction of hepatic endothelial cells, especially the subtypes characterized with proliferation and differentiation. Macrophages were recruited during sepsis and released inflammatory cytokines (Tnf, Il1b, Il6), chemokines (Ccl6, Cd14), and transcription factor ( Nfkb1), resulting in liver inflammatory responses. Massive apoptosis of lymphocytes and abnormal recruitment of neutrophils caused immune dysfunction. ART treatment significantly improved the survival of CLP mice within 96 h, and partially relieved or reversed the above-mentioned pathological features, mitigating the impact of sepsis on liver injury, inflammation, and dysfunction. This study provides comprehensive fundamental proof for the liver protective efficacy of ART against sepsis infection, which would potentially contribute to its clinical translation for sepsis therapy.
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
通讯
资助项目
Establishment of Sino-Austria "Belt and Road" Joint Laboratory on Traditional Chinese Medicine for Severe Infectious Diseases and Joint Research[2020YFE0205100] ; National Key Research and Development Program of China["2020YFA0908000","2022YFC2303600"] ; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine[ZYYCXTD-C-202002] ; National Natural Science Foundation of China["82141001","82274182","82074098","82173914"] ; CACMS Innovation Fund["CI2021A05101","CI2021A05104"] ; Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences[CI2021B014] ; Science and Technology Foundation of Shenzhen[JCYJ20210324115800001] ; Fundamental Research Funds for the Central Public Welfare Research Institutes["ZZ14-YQ-050","ZZ14-YQ-051","ZZ14-YQ-052","ZZ14-FL-002","ZZ14-ND-010","ZZ15-ND-10"] ; Shenzhen Governmental Sustainable Development Fund[KCXFZ20201221173612034] ; Shenzhen Key Laboratory of Kidney Diseases[ZDSYS201504301616234] ; Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties[SZGSP001]
WOS研究方向
Chemistry ; Pharmacology & Pharmacy
WOS类目
Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
WOS记录号
WOS:000969020000001
出版者
ESI学科分类
PHARMACOLOGY & TOXICOLOGY
来源库
Web of Science
引用统计
被引频次[WOS]:5
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/583130
专题南方科技大学第一附属医院
作者单位
1.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China
2.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
3.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Dept Nephrol,Shenzhen Key Lab Kidney Dis, Shenzhen 518020, Peoples R China
4.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Shenzhen Clin Res Ctr Geriatr, Shenzhen 518020, Peoples R China
5.Jiangxi Univ Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese He, Nanchang 330004, Peoples R China
6.China Acad Chinese Med Sci, Beijing 100700, Peoples R China
7.Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore
8.Stanford Univ, Sch Med, Adv Drug Delivery & Regenerat Biomat Lab, Stanford, CA 94304 USA
9.Stanford Univ, Sch Med, Cardiovasc Pharmacol Div Cardiovasc Inst, Stanford, CA 94304 USA
10.Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Prote, Guangzhou 510515, Peoples R China
第一作者单位南方科技大学第一附属医院
通讯作者单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
He, Xue-ling,Chen, Jia-yun,Feng, Yu-lin,et al. Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate[J]. ACTA PHARMACOLOGICA SINICA,2023.
APA
He, Xue-ling.,Chen, Jia-yun.,Feng, Yu-lin.,Song, Ping.,Wong, Yin Kwan.,...&Wang, Ji-gang.(2023).Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate.ACTA PHARMACOLOGICA SINICA.
MLA
He, Xue-ling,et al."Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate".ACTA PHARMACOLOGICA SINICA (2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[He, Xue-ling]的文章
[Chen, Jia-yun]的文章
[Feng, Yu-lin]的文章
百度学术
百度学术中相似的文章
[He, Xue-ling]的文章
[Chen, Jia-yun]的文章
[Feng, Yu-lin]的文章
必应学术
必应学术中相似的文章
[He, Xue-ling]的文章
[Chen, Jia-yun]的文章
[Feng, Yu-lin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。